Replies to post #39464 on Pluristem Therapeutics Inc (PSTI)

[zzaatt]

Hi saud, yeah, it would (will ?? ) be nice. With AUPH we do have the advantage of a successful P3 in the bag, that does wonders for the probability of FDA approval.

As far as Pluristem, we have a number of shots at the target, we only need one to have a very substantial increase in PPS. Given the current valuation, I think a 5 to 10 bagger (to begin with) is easily possible. We do need that one clinical success!!!